Literature DB >> 19505226

Ocular preservatives: associated risks and newer options.

Indu Pal Kaur1, Shruti Lal, Cheena Rana, Shilpa Kakkar, Harinder Singh.   

Abstract

Presence of a preservative in an ocular medication has often been considered a culprit in damaging the epithelium. However, the inclusion of a preservative is equally necessary, especially in multiple-dose containers, in order to protect against dangerous organisms accidentally gaining access during instillation. Benzalkonium chloride (BAK), chlorobutanol, chlorhexidine acetate (CHA), and phenylmercuric nitrate or acetate are some commonly used preservatives in eye preparations. New preservatives with a wide range of activity and good safety profiles have been introduced in the market, such as stabilized oxychloro complex (SOC), sofZia, and sodium perborate. In the present review, we discuss various conventional and newly proposed and patented preservative molecules for ocular use. Reasons for discontinuing traditional preservatives and the need for less-toxic molecules are discussed at length, along with newer options coming up in this area.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19505226     DOI: 10.1080/15569520902995834

Source DB:  PubMed          Journal:  Cutan Ocul Toxicol        ISSN: 1556-9527            Impact factor:   1.820


  24 in total

1.  Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT™) in patients with elevated intraocular pressure in a randomized clinical trial.

Authors:  Arthur Shedden; Ingrid A Adamsons; Albert J Getson; Jean K Laurence; Christopher R Lines; David J Hewitt; Tony W Ho
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-02       Impact factor: 3.117

2.  Potential toxicity of topical ocular solutions.

Authors:  Nevio Cimolai
Journal:  CMAJ       Date:  2019-08-12       Impact factor: 8.262

3.  Balancing antimicrobial efficacy and toxicity of currently available topical ophthalmic preservatives.

Authors:  Elmer Y Tu
Journal:  Saudi J Ophthalmol       Date:  2014-06-23

4.  New Classes of Polycationic Compounds as Preservatives for Ophthalmic Formulations.

Authors:  Dörte von Deylen; Christina Dreher; Oliver Seidelmann; Stephan Reichl
Journal:  Pharm Res       Date:  2018-11-08       Impact factor: 4.200

5.  Effects of benzalkonium chloride on the ocular surface of the rabbit.

Authors:  Jae Ryun Kim; Tae Hoon Oh; Hyun Seung Kim
Journal:  Jpn J Ophthalmol       Date:  2011-05-03       Impact factor: 2.447

Review 6.  Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages.

Authors:  Gábor Holló; Andreas Katsanos; Kostas G Boboridis; Murat Irkec; Anastasios G P Konstas
Journal:  Drugs       Date:  2018-01       Impact factor: 9.546

Review 7.  The ocular surface epithelial barrier and other mechanisms of mucosal protection: from allergy to infectious diseases.

Authors:  Flavio Mantelli; Jerome Mauris; Pablo Argüeso
Journal:  Curr Opin Allergy Clin Immunol       Date:  2013-10

8.  Development of a non-settling gel formulation of 0.5% loteprednol etabonate for anti-inflammatory use as an ophthalmic drop.

Authors:  Martin J Coffey; Heleen H Decory; Stephen S Lane
Journal:  Clin Ophthalmol       Date:  2013-02-13

9.  Efficacy and patient tolerability of travoprost BAK-free solution in patients with open-angle glaucoma and ocular hypertension.

Authors:  Sophia K Mirza; Sandra M Johnson
Journal:  Clin Ophthalmol       Date:  2010-08-09

Review 10.  Ocular benzalkonium chloride exposure: problems and solutions.

Authors:  Michael H Goldstein; Fabiana Q Silva; Nysha Blender; Trung Tran; Srilatha Vantipalli
Journal:  Eye (Lond)       Date:  2021-07-14       Impact factor: 4.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.